March 27 (Reuters) - Twenty-eight million people face acute hunger in the Democratic Republic of Congo, a record for the country, driven by an escalating conflict between the government and ...

March 28 (Reuters) - Qatar hosted a second round of talks on Friday between Congo and Rwanda and separately met with representatives of the Rwandan-backed rebellion waging an insurgency in eastern ...

But we need your help to accomplish this; add your name to our petition to Protect Christians From Massacre in the Congo. Then tell your church leaders to engage, speak out against the persecution ...

Rwandan-backed M23 rebels have taken control of two major cities in eastern DR Congo in the past two months China's efforts to build up huge business interests across Africa have been accompanied ...

M23 seizes mining hub, with rebel alliance leader saying call for a ceasefire from DRC and Rwanda ‘doesn’t concern us’. The three countries call for ‘immediate and unconditional ceasefire ...

Box Office Collection Worldwide: Unveiling the Pinnacle of Worldwide Movie Success In the realm of global cinema, certain films transcend borders and captivate audiences on an unprecedented scale ...

Copyright 2025 The Associated Press. All Rights Reserved. Rebel leader of group of Alliance Fleuve Congo (AFC) including M23, Corneille Nangaa, addresses a news ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

The trial comprise 502 participants, 101 of whom were Japanese. Credit: aslysun/Shutterstock. Genmab has received approval from the Japan’s Ministry of Health, Labour and Welfare for Tivdak (tisotumab ...

The company is focused on developing therapeutics targeting toxic soluble AβOs for treating Alzheimer’s disease. Credit: Chinnapong / Shutterstock. Acumen Pharmaceuticals has concluded enrolment for ...

Ionis is set to continue handling the therapy’s commercialisation in the US. Credit: Ionis Pharmaceuticals, Inc. Ionis Pharmaceuticals has entered a licence agreement with Sobi in which the latter ...

The trial involves obese or overweight volunteers and subjects without diabetes mellitus. Credit: oatawa / Shutterstock. US-based biopharmaceutical company Helicore Biopharma has dosed the first ...